Adrian W. Quartel
CIK: 0001910132
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 27, 2026SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectRestricted Stock Units
13K shares- - Jan 30, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Exercise(M)Direct11.3K shares- - Jan 30, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Sale(S)Direct4.5K shares at avg. $8.83$40K - Jan 29, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Unit
37.5K shares- - Jan 29, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
75K shares- - Jan 30, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
68K shares- - Jan 30, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Unit
34K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 27, 2026 |  SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Restricted Stock Units | 13,000 | - | - | Direct |
| Jan 30, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Exercise(M) | 11,333 | - | $0 | Direct |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale(S) | 4,533 | $8.83 | $40,036 | Direct |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Restricted Stock Unit | 37,500 | - | - | Direct |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jan 30, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 68,000 | - | - | Direct |
| Jan 30, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Restricted Stock Unit | 34,000 | - | - | Direct |
1-7 of 7 transactions
About Quartel Adrian W
Quartel Adrian W (SEC CIK 0001910132) files insider reports with the SEC as Chief Medical Officer of SPRUCE BIOSCIENCES, INC. (SPRB) and Chief Medical Officer of ZEVRA THERAPEUTICS, INC. (ZVRA).
Signal8 holds 5 ownership filings by Quartel Adrian W (2 Form 3, 3 Form 4), filed between Mar 27, 2025 and Jul 29, 2026. Those filings report 7 transactions, from Jan 30, 2025 to Jul 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Quartel Adrian W's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Quartel Adrian W
- Jul 27, 2026: Grant or award of SPRB derivative securities (Form 4, code A).
- Jan 30, 2026: Option exercise of ZVRA shares (Form 4, code M).
- Jan 30, 2026: Open-market sale of ZVRA shares (Form 4, code S).
- Jan 29, 2026: Grants or awards of ZVRA derivative securities (2 lines, Form 4, code A).
- Jan 30, 2025: Grants or awards of ZVRA derivative securities (2 lines, Form 4, code A).
Other insiders filing for SPRUCE BIOSCIENCES, INC. (SPRB)
- Szwarcberg Javier B., CHIEF EXECUTIVE OFFICER
- SPIEGELMAN DANIEL K, Director
- SIMPSON CAMILLA V, Director
- GREY MICHAEL G, Executive Chairman
- Barretto-Ko Percival, Director
- Walbert Keli, Director